Synthesis and Evaluation of Thiadiazole-based Antileishmanial Agents
Authors
Abstract
Background and Objectives: The 1, 3, 4-thiadiazole scaffold is one of the principal structural components, in a variety of drug categories such as antimicrobial, anti-inflammatory, antineoplastic, and antileishmanial agents. Considering the reported antileishmanial effects of thiadiazole derivatives and the importance of this disease, some of the thiadiazole derivatives with modifications at sulfur atom or amine group attached to the 2-position were synthesized and evaluated for antileishmanial activity.
Materials and Methods: Derivatives of 1,3,4-thiadiazole including 2-substituted-thio-1,3,4-thiadiazoles bearing (5-(4-nitrobenzylideneamino) or 5-amino (II, IV, V) and one derivative of 2-substituted-amino- 1,3,4-thiadiazole bearing (5- (4-nitrophenyl) (VII) were synthesized and evaluated for their in vitro antileishmanial activity against promastigote and amastigote forms of the Leishmania major.
Results: The most active compound was found to be compound II after 24-h incubation against promastigotes and amastigotes with the half maximal inhibitory concentration (IC50) values of 44.4 μM and 64.7 μM, respectively.
Conclusion: All of the synthesized compounds showed good antileishmanial activity against both forms of L. major after 48 and 72 h incubation.
Copyright
© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major
Sadat-Ebrahimi SE, Mirmohammadi M, Mojallal Tabatabaei Z, Azimzadeh Arani M, Jafari-Ashtiani S, et al. Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major. Iran J Pharm Res. 2019;18(4):e124697. doi: https://doi.org/10.22037/ijpr.2019.14547.12476
Synthesis and In Vitro Anti-Leishmanial Evaluation of 1 -( 5 - Halo- 2 -Thienyl)- 2 -[5 -(5-Nitroheteroaryl)]-1 ,3 ,4 -Thiadiazol- 2 - Ylthio)Ethanone Derivatives
Adibi H, Foroumadi A, Heidari O, Aliabadi A, Kabudanian Ardestani S. Synthesis and In Vitro Anti-Leishmanial Evaluation of 1 -( 5 - Halo- 2 -Thienyl)- 2 -[5 -(5-Nitroheteroaryl)]-1 ,3 ,4 -Thiadiazol- 2 - Ylthio)Ethanone Derivatives. J Rep Pharm Sci. 2012;1(2):e147768. doi:
Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines
Foroumadi A, Adibi H, Kabudanian Ardestani S, Shirooie S, Bozorgomid A, et al. Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines. Iran J Pharm Res. 2017;16(3):e124964. doi: https://doi.org/10.22037/ijpr.2017.2071
Synthesis and Antimycobacterial Activity of some Triazole Derivatives–New Route to Functionalized Triazolopyridazines
Tehrani KHME, Mashayekhi V, Azerang P, Minaei S, Sardari S, et al. Synthesis and Antimycobacterial Activity of some Triazole Derivatives–New Route to Functionalized Triazolopyridazines. Iran J Pharm Res. 2015;14(Suppl):e125274. doi: https://doi.org/10.22037/ijpr.2015.1713
Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity
Aliabadi A, Hasanvand Z, Kiani A, Mirabdali SS. Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity. Iran J Pharm Res. 2013;12(4):e125741. doi: https://doi.org/10.22037/ijpr.2013.1363
- Scopus by DOI: 6
Last Update: 3 days ago
- Scopus by Title: 6
Last Update: 3 days ago
- Scopus by Title (Ref): 6
Last Update: 3 days ago
- CrossRef: 6
Last Update: 5 days ago